Ani (Ani)
Casodex Tablet
Product Images NDC 62559-680
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Casodex (NDC 62559-680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chem (Image 01)
Fig_1 (Image 02)
Fig_2 (Image 03)
The text describes a study comparing two different treatments for a medical condition, possibly related to cancer. The treatments are referred to as "Casodex plus LHRH-A N" and "Flutamide plus LHRH-A". The study seems to measure the proportion of patients who do not progress under each treatment, over a period of up to 1460 days. The number "1825" may refer to the total duration of the study.*
Image 04
This is a description of a medication called CASODEX, which is a trademark of AstraZeneca group of companies, and licensed to ANI Pharmaceuticals. The medication contains Bicalutamide and comes in tablets of 50 mg each. Please check the accompanying prescribing information for dosage instructions. The medication should be stored at a controlled room temperature and kept out of the reach of children. The tablets are manufactured by Corden Pharma GmbH in Germany and distributed by ANI Pharmaceuticals in Minnesota. The text includes a National Drug Code (NDC) and a Global Trade Item Number (GTIN).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
